OBJECTIVE: This scoping review aims to understand the extent and type of evidence about innovative external prototypes for patients who undergo DC while awaiting CP.
METHODS: This scoping review will use the Joanna Briggs Institute methodology for scoping reviews. This scoping review will include noninvasive medical devices for adult patients who undergo DC while waiting for CP. The search strategy will be implemented in MEDLINE, Embase, Web of Science, Scielo, Scopus, and the World Health Organization (WHO) Global Health Index Medicus. Patent documents were also allocated in Espacenet, Google Patents, and the World Intellectual Property Organization (WIPO) database.
RESULTS: This scoping review is not subject to ethical approval as there will be no involvement of patients. The dissemination plan includes publishing the review findings in a peer-reviewed journal and presenting results at conferences that engage the most pertinent stakeholders in innovation and neurosurgery.
CONCLUSIONS: This scoping review will serve as a baseline to provide evidence for multidisciplinary teams currently designing these noninvasive innovations to reduce the risk of associated complications after DC, hoping that more cost-effective models can be implemented, especially in low- and middle-income countries.
UNASSIGNED: DERR1-10.2196/50647.
目的:本范围审查旨在了解在等待CP期间接受DC的患者的创新外部原型证据的范围和类型。
方法:此范围审查将使用JoannaBriggsInstitute方法进行范围审查。此范围审查将包括等待CP时接受DC的成年患者的非侵入性医疗设备。搜索策略将在MEDLINE中实施,Embase,WebofScience,Scielo,Scopus,和世界卫生组织(世卫组织)全球健康指数药物。专利文件也在Espacenet中分配,谷歌专利,和世界知识产权组织(WIPO)数据库。
结果:此范围审查不受伦理批准,因为不会涉及患者。传播计划包括在同行评审的期刊上发表评论结果,并在与创新和神经外科最相关的利益相关者互动的会议上展示结果。
结论:这项范围审查将作为基线,为目前设计这些非侵入性创新的多学科团队提供证据,以降低DC后相关并发症的风险,希望能够实施更具成本效益的模式,特别是在低收入和中等收入国家。
■DERR1-10.2196/50647。